Beat AML: Personalized Medicine for Acute Myeloid Leukemia Based on Functional Genomics
The purpose of this study is to profile AML cancer cell molecular diagnostics and patient pharmacogenetics to simulate cancer cell function and screen for FDA approved drugs with anti-neoplastic activity and predict adverse events to prescribed treatments.
KeywordsAcute myeloid leukemia, Leukemia, Leukemia - resources
Principal InvestigatorChristopher R Cogle, M.D.
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.